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ABSTRACT 
The main objective of method validation process is to prove that an analytical method is acceptable 
for its intended purpose. The necessity for laboratories to use fully validated methods is now 
universally accepted as a way to obtain reliable results. There are diverse documents for method 
validation including information about different performance parameters. The classical performance 
characteristics are accuracy, limit of detection, precision, recovery, robustness, ruggedness, 
selectivity, specificity and trueness. Unfortunately, contradictory information is normally present 
among the method validation documents used by laboratories. The inconsistency about the 
performance parameters can generate some degree of confusion in the complete method 
validation process. This manuscript addresses controversial and discrepant information, focusing 
specifically on several national and international method validation guidelines published by 
prominent organizations and institutions which serve as guidance to validate new analytical 
methods by practitioners working in different fields. 
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1. Introduction  1 
Method validation (MV) is the process of proving that an analytical method is acceptable 2 
for its intended purpose. That means the ultimate objective of the MV process is to provide 3 
evidence that the method can provide reliable results. Analytical MV is carried out to 4 
ensure that every future measurement in routine analysis will be close enough to the 5 
unknown true value for the content of the analyte in the sample. It is absolutely important 6 
not to mix the terms analytical and bioanalytical methods as they both serve different 7 
purposes and cover different parameters for their particular validation procedures. 8 
Unfortunately, there is some misleading information in the literature because the term 9 
bioanalytical method validation is used to refer to the quantitative determination of drugs 10 
and/or metabolites in fluids and other biological matrices (blood, serum, plasma, urine, 11 
faeces, tissue skin). But really, this type of laboratory analysis that use such matrices 12 
should also be considered as analytical determinations. Thus, there are few techniques 13 
such as conventional chromatographic based methods (GC and HPLC) sometimes in 14 
combination with mass spectrometry (GC-MS and LC-MS) that can be used for diverse 15 
matrices. These techniques are very popular in routine laboratories belonging to different 16 
analytical environments. At this point it is appropriate to clarify that this document is 17 
focused on analytical MV and, therefore, bioanalytical chemistry and genuine biochemical 18 
analysis are outside its scope. 19 
When a laboratory is interested in performing a new analytical procedure, one of the most 20 
important steps is its validation. The necessity for laboratories to use a fully validated 21 
method of analysis is now universally accepted and/or required within many sectors of 22 
analysis. In any case, although MV is an important requirement in the practice of chemical 23 
analysis, the general understanding among practitioners to why, when and what should be 24 
done for MV appears to be poor. This fact is due to frequent discrepancies among 25 
documents relating to MV published in the literature. As a consequence, there are some 26 
risks and problems when trying to work in the laboratory using contradictory definitions and 27 
requirements for the different validation parameters [1–6].  28 
This manuscript has three main objectives. Firstly, to highlight the importance of the MV, 29 
drawing attention to the many problems that may be caused if an incorrect validation 30 
procedure is used. Secondly, to compile the numerous national and international 31 
regulatory documents or guidelines for analytical MV. Thirdly, to present a critical 32 
discussion among existing MV guidelines to emphasize possible pitfalls and expected 33 
trends that arise from MV to results assessment. Thus, important information including 34 
controversies and discrepancies (C&D) may be used as guidance by practitioners or 35 
scientists needing to validate new analytical methods. 36 
 37 
2. Guidelines for MV 38 
Many international guidelines and publications concerning MV were published in the 39 
literature. For this manuscript, the 37 different documents summarized in Table 1 were 40 
evaluated [7–42]. The criteria for inclusion of guidelines was to try to compile the maximum 41 
number of documents previously reported in the literature. Previous comparative studies of 42 
MV guidelines used a limited number of documents, among 3-6 [1-6]. The documents can 43 
be classified according to diverse factors such as: i) matrix of samples (analytical versus 44 
biological); ii) national or international level; iii) area or discipline; iv) analytical technique; 45 
v) compounds analysed. In general, there are few MV guidelines dedicated to evaluate 46 
biological samples. Most of the documents are promoted by international organizations 47 
and regulatory agencies. The most frequent disciplines are pharmaceutical, environmental, 48 
toxicological and food analysis. The majority of documents can be used for any analytical 49 
 5 
technique, although some of the documents were specific for chromatography 1 
determinations. Similarly, most of the documents were not focused to determine specific 2 
compounds but some of them are dedicated to pesticides analysis. 3 
 4 
3. Inconsistencies among MV guidelines 5 
3.1. Description of general factors 6 
The realization of MV is not a single and universal procedure. The variability among MV 7 
guidelines may be related to the following different factors: 8 
1st. Area of application and terminology. The biggest problem encountered about MV is the 9 
terminology employed in the extensive literature. When comparing documents, identical 10 
terms may be defined in different ways. In addition, some of the performance parameters 11 
are often used interchangeably and/or incorrectly. One of the reasons could be that the 12 
technical terms used for analytical methods vary in different sectors of analytical 13 
measurement. This ambiguity or misinterpretation in the terminology can lead in some 14 
instances to wrong scientific conclusions. It is important to consider that the harmonization 15 
in MV vocabulary is required for a discussion between scientists of the same or different 16 
analytical fields. For this purpose, the international vocabulary of metrology (VIM) was 17 
developed to describe measurements that can be used in different fields [43].   18 
2nd. Particular purpose. Initially, analytical methods can be used for qualitative and 19 
quantitative determinations, although this document is only dedicated to the latter. 20 
Furthermore, quantitative analytical methods can be used for different purposes, such as 21 
product development, process control, quality control and research. This fact can vary the 22 
MV procedure. For example, research validation works are normally carried out in perfect 23 
experimental conditions while the use of the same method in a routine laboratory needs a 24 
more systematic scheme for the internal validation procedure. Additionally, to check that 25 
method performance parameters are effective when the method is in repetitive use, 26 
validation should be appropriately evaluated in the laboratory including internal quality 27 
control activities.  28 
3rd. Analytical techniques. There are different techniques to be used such as 29 
chromatography (GC, HPLC, TLC), capillary electrophoresis (CE), spectrophotometry 30 
(UV/VIS, IR, fluorescence, AAS, ICP) or spectrometric techniques (NMR, MS) as well as 31 
the hyphenated methods. They have their own special features which should be 32 
considered in detail for MV procedure. 33 
4th. Validation parameters. The classical performance parameters are accuracy, precision, 34 
linearity and application range, limit of detection (LOD), limit of quantitation (LOQ), 35 
selectivity/specificity, recovery and robustness/ruggedness. It is possible that some 36 
validation documents consider complementary performance parameters such as carry-37 
over, stability and system suitability studies. 38 
5th. Experimental procedures. Although there is a general agreement among literature in 39 
terms of validation parameters, significant diversity exists with respect to the methodology 40 
employed. Many documents are usually restricted to general concepts [44] and there is 41 
frequently a lack of advice for the practical execution of MV studies [45]. Additionally, there 42 
are no official guidelines on the correct sequence of validation experiments, and the 43 
optimal sequence may depend on the method itself [46]. 44 
6th. Acceptance criteria. Only few criteria are normally provided to define the acceptance 45 
during MV. In part, this may be because acceptability is determined by the purpose served 46 
by the method and thus a broad overview of validation cannot address the differing 47 




3.2.  Description of inconsistencies in performance parameters 1 
3.2.1. Selectivity/Specificity 2 
Obtaining a signal free unequivocally from the influence of other species contained in the 3 
sample is for reliable chemical measurement processes. In fact, the inexistence of 4 
interferences can be considered as the hallmark of any determination at laboratory level. 5 
Thus, if the analytical method is not free from the effect of possible interferences, all other 6 
performance parameters are less reliable [47]. 7 
Selectivity can be based on the detection system (e.g. atomic emission spectrometry) or 8 
separation process (e.g. chromatography). Hyphenated techniques (e.g. GC/LC-MS) can 9 
be applied when the demands for response signal free of interferences are especially high 10 
by combining selectivity from separation and detection processes. 11 
 12 
[C&D-N1]. Terminology. The degree of interferences for analytical methods can be 13 
considered controversial because two terms such as selectivity and specificity co-exist. 14 
Despite the clear difference between the two terms, they are used interchangeably or 15 
erroneously, especially in the field of chromatography [48]. By one hand, the term 16 
specificity is used for single component analysis when a method is free from interferences 17 
and only determines the intended analyte. Thus, only a small number of biochemical 18 
methods relating to enzymatic and immunochemical determinations can be considered 19 
specific in the sense defined above. On the other hand, selectivity refers to 20 
multicomponent analysis as the extent to which it can determine one particular analyte or 21 
analytes in a complex mixture without interference from other components also present in 22 
the mixture. Additionally, IUPAC suggests that the term specific, in the analytical field, is 23 
considered as the ultimate of selectivity [49]. Also it is important to note the distinction of 24 
concepts included in the SANTE guideline for both parameters [33]. Selectivity is used to 25 
discriminate between the analyte of interest and other compounds while specificity is 26 
defined as the ability to provide signals to effectively identify the analyte. Therefore, this 27 
guideline differentiates among methodologies as selective/non-specific (e.g. GC-ECD), 28 
non-selective/specific (e.g. GC-MS) and selective/specific (e.g. HR-MS). 29 
  30 
3.2.2. Calibration curve/Linearity/Response function 31 
The analytical calibration represents the relationship between known amounts of the 32 
analyte in the sample and the response of the instrument. This procedure should be done 33 
during the early stage of the MV. Unfortunately, the experimental design for analytical 34 
calibration is not well described in all the documents. A detailed discussion on the strategy 35 
to carry out a calibration curve is beyond the scope of this article. Thus, the most important 36 
aspects in the experimental planning for analytical calibration are only cited: i) The type of 37 
the calibration samples, either matrix-containing or matrix-free; ii) The calibration 38 
methodology (external standard, internal standard or standard addition); iii) The range of 39 
concentrations and the distribution of the points along the calibration curve; iv) The 40 
number of replicate measurements for each calibration level; vi) The number of series or 41 
different calibration curves.  42 
[C&D-N2]. Terminology. Many MV guidelines explaining that analytical calibration model 43 
should be chosen based on the linearity of experiments. Although the term linearity is 44 
generally accepted, this is not a very clear terminology [50]. 45 
 46 
[C&D-N3]. Selection of the calibration model. It must be pointed that the choice of an 47 
appropriate calibration model or response function is crucial for the quality of data that can 48 
be obtained with a given method during its routine application. In general, MV guidelines 49 
recommend to apply the simplest model that adequately describes the concentration–50 
 7 
signal relationship and the use of more complex models should be justified. However, this 1 
is not always easy to implement in practice due to two important subjects such as: 2 
 The linearity of experiments. Although a linear relationship between instrument 3 
signal and analyte concentration is the simplest situation, the trends including non-4 
linear response are very frequent for routinely laboratory work. Therefore, the use of 5 
quadratic or superior regression models may be necessary to avoid leverage points 6 
and deviations at low concentration levels [51]. 7 
 8 
 The selection of the fitting technique: Ordinary (OLS) versus weighted least squares 9 
(WLS). Calibration curves must be calculated by OLS linear regression, which 10 
assumes that variance is independent of the analyte concentration 11 
(homoscedasticity). But if the variance of the replicates at each concentration level 12 
is not constant through the linear range (heteroscedasticity), then a better option is 13 
to use the WLS regression method, which takes into account the individual variance 14 
values in each calibration point. Calibration ranges that span at least two or three 15 
orders of magnitude are usually related with significant heteroscedasticity, which is 16 
the very frequent situation for bioanalytical methods [52].  17 
 18 
[C&D-N4]. Acceptance criteria. Different procedures were reported to evaluate the 19 
choice of the curve fitting such as graphically (scatter, residuals and sensitivity plots), 20 
statistically (ANOVA-lack of fit, Mandel test and significance of quadratic term test) and by 21 
numerical parameters (r and/or R2, and % relative error or deviation from nominal values) 22 
[53]. One big problem is the lack of equivalence among some of the procedures typically 23 
applied to evaluate curve fitting [51]. In addition, one of the most controversial subjects 24 
relating to the evaluation of curve fitting is to check the linearity of a calibration curve by 25 
inspection of the correlation coefficient [50, 53]. At this point, it is important to clarify the 26 
difference between correlation and regression terms because many times they are used 27 
interchangeably. Correlation coefficient (r) describes the presence of a linear relationship 28 
between two observed variables, and the degree of association should be negative or 29 
positive. Contrarily, determination coefficient (R2) does not care about the sign of the 30 
variation and it shows the association type by explaining the model. Therefore, r should be 31 
used to indicate the strength and direction of a linear relationship, while R2 should be used 32 
to design the proportion of explained variance. However, although r and R2 are widely 33 
reported for calibration curves, it is important to note that both parameters are unsuitable 34 
for goodness-of-fit regression evaluation [53]. In any case, the final decision about curve 35 
fitting should be made according the percentage of relative error (% RE) [51]. 36 
 37 
3.2.3. Accuracy  38 
It is important to point out that accuracy is the most crucial parameter that any analytical 39 
method should address because it allows for estimating total error affecting the method 40 
[54].  41 
 42 
[C&D-N5]. Terminology: one versus two parameters. In a strict sense, accuracy is only 43 
related to systematic error. This simple definition of accuracy as one simple parameter is 44 
thoroughly accepted in the bioanalytical field [55]. On the contrary, in a widespread sense, 45 
the term accuracy is considered as a function of random and systematic errors. Thus, 46 
accuracy is a dual parameter concept as a way to define the total analytical error. Then, 47 
the term precision is related to random error and the term trueness is related to systematic 48 
error [54]. There is an important difference between both precision and trueness. Although 49 
 8 
the precision can be decreased, it cannot be fully eliminated. In contrast, trueness 1 
correction is in principle possible, although this is another controversial subject [19]. 2 
[C&D-N6]. Experimental procedure: single versus combined experiments. The 3 
evaluation of accuracy (or trueness) can be found together with precision in the form of 4 
combined experiments. On the contrary to parallel experiments, accuracy (or trueness) 5 
and precision are also determined by using separate tests. In this situation, precision of 6 
experiments should be checked previously to accuracy (or trueness) because precision 7 
affects evaluation of systematic error, but not vice versa. In any case, the accuracy 8 
samples should ideally be obtained from an independent source rather than the same from 9 
calibration curve and they should be as closely related to the unknown samples as 10 
possible. 11 
 12 
3.2.4. Precision 13 
Precision characterizes the closeness of agreement between the measured values 14 
obtained by replicate measurements on the same or similar objects under specified 15 
conditions [48]. Precision is generally assessed by repeated analysis of validation samples 16 
and it is usually expressed in the form of ―imprecision‖ such as absolute standard deviation 17 
(s or SD), relative standard deviation (RSD), coefficient of variation (CV) or variance (s2). 18 
Although the precision of an assay is constant over most of the range of an assay, the 19 
analysts should take into consideration that experimental precision shows a large 20 
variability, mainly decreasing at the extreme levels [56]. Therefore, testing precision is also 21 
essential at the bottom and top of the experimental range. 22 
 23 
[C&D-N7]. Precision levels. Different terms are normally associated with random errors 24 
such as repeatability, intermediate precision and reproducibility [50]. The differences 25 
among precision levels are made by the concept of series or runs. Diverse factors such as 26 
operators, reagents, days and/or equipment can be varied during series/runs. The 27 
selection of the factors should be done according to the experimental conditions that will 28 
be found during the routine use of the analytical procedure. 29 
On the other hand, it is important to note that the first type of precision that should be 30 
considered for MV is the instrument precision [57], also named as injection repeatability 31 
[3]. This instrument precision should be checked through replicate injections performed in 32 
repeatability conditions of the same solution at one considerable high concentration from 33 
the working range. It is calculated according to instrument signal, which depends on the 34 
technique used (e.g. Chromatography, checking the retention time and peak area; e.g. 35 
Ultraviolet and Visible measurements, checking the absorbance or transmittance at the 36 
selected wavelength). 37 
 38 
[C&D-N8]. Terminology. Common terms to express the repeatability are within/intra-day,  39 
-assay, -batch and -run. Similarly, expressions for reproducibility of the analytical method 40 
are between/inter-day, -assay, -batch and -run. However, the expressions intra/within-day 41 
and inter/between-day precision are not preferred, because a set of measurements could 42 
take longer than one day or multiple sets could be analysed within the same day. 43 
Another important subject about terminology is to distinguish between the terms 44 
intermediate precision and reproducibility because in some documents both terms are 45 
used interchangeably. The term intermediate precision should be used for single 46 
laboratory, while reproducibility should be associated with the random error obtained by 47 
many laboratories. Therefore, it should be pointed out that it is wrong to report the 48 
reproducibility precision for single laboratory and such a term should never be used. If the 49 
term reproducibility is used for one laboratory, to avoid misunderstanding, the term intra-50 
 9 
laboratory also must be used together. In this line, some documents can describe the 1 
reproducibility precision using two terms, intra-laboratory for single laboratory and inter-2 
laboratory when multiple laboratories are validating one shared method. 3 
3.2.5. Trueness 4 
Trueness relates to the systematic error of a measurement system. Rigorously defined, 5 
refers to the agreement between the average of infinite number of replicate measured 6 
values and the true value of the measured quantity. In practice, trueness is evaluated from 7 
a finite but reasonably large number of measurements and reference values are used 8 
instead of the true value [54]. Trueness can be determined in one of four ways: i) By 9 
analysing a sample of known concentration (Certified Reference Material) similar to the 10 
routine sample and comparing the measured value to the true value; ii) Comparing test 11 
results from the method with results from an existing alternate method that is known to be 12 
reliable; iii) Based on the spiking of known amounts of analyte into sample matrix; iv) 13 
Using the technique of standard addition, which can be used in the case of matrix effect. 14 
The pros and cons of common approaches for determining trueness can be found 15 
elsewhere [58]. 16 
 17 
[C&D-N9]. Terminology. The trueness of an analytical method can be quantitatively 18 
expressed using three different terms such as bias, relative bias and recovery [59]. Firstly, 19 
bias is defined, in practice, as the difference between the mean obtained with a large 20 
number of replicate measurements and a reference value. Secondly, relative bias is 21 
calculated in similar manner considering the difference but also the reference value. 22 
Finally, recovery term should be used to denote the ratio of the concentration found versus 23 
the reference value. Therefore, the term trueness should be well explained in the 24 
validation document because frequently it is interchanged with other terms such as 25 
accuracy, bias and recovery.  26 
 27 
3.2.6. Recovery 28 
Although it is desirable to attain a recovery factor as close to 100% as possible, there is 29 
not a minimum established value. Therefore, an analytical method with low recovery could 30 
be suitable for a certain analyte if the sensitivity of the method is appropriate. 31 
 32 
[C&D-N10]. Terminology. The general term recovery has been used in the literature in 33 
different situations. IUPAC explain that the term recovery is used in two distinct contexts 34 
that should be distinguished theoretically and also with a clear and different terminology 35 
[60]. By this way, the yield of a pre-concentration or extraction stage of an analytical 36 
process has been defined as absolute recovery, recovery factor or simply recovery. On the 37 
contrary, the ratio of observed value versus a reference value obtained using an analytical 38 
procedure that involves a calibration graph has been defined as relative or apparent 39 
recovery.   40 
 41 
3.2.7. Limit of detection 42 
This is an important figure of merit in the analytical chemistry field although it is not 43 
necessary to calculate during the process of validation of all analytical methods. The 44 
estimation of this parameter is especially important when trace and ultra-trace quantities of 45 
analyte are to be distinguished. Contrarily, LOD estimation for quantitative determinations 46 
at high concentration levels are omitted in the majority of MV guidelines. This is a greatly 47 
controversial performance parameter from both theoretical and experimental point of views 48 
with a lack of overall understanding and major differences in the terminology and the 49 







[C&D-N11]. Terminology. In general, there are many options in the literature to describe 6 
measurement limits. The most frequent terms suggested by the chemical community to 7 
describe detection and quantification capabilities are critical value or decision limit; 8 
minimum detectable value or detection limit and minimum quantifiable value or 9 
quantification limit [61]. Some MV guidelines have presented alternative names but with 10 
similar definition. It is important to highlight that LOD is not the analyte level for deciding 11 
between detected and not detected [62]. The majority of definitions include terms such as 12 
confidence, probability and reliability, that denotes the use of statistics to calculate them. In 13 
fact, LOD is derived from the theory of hypothesis testing and the probabilities of false 14 
positives (α) and false negatives (β). Some of the conceptual problems caused by 15 
common definitions are solved by the use of alternative terms CCα (decision limit) and 16 
CCβ (detection capability) [63]. In addition, it is possible to find information about 17 
instrument LOD and method LOD. These terms refer to the instrument capabilities and the 18 
whole method, respectively. Finally, it should also be noted that the word sensitivity has 19 
been used incorrectly in place of LOD [64]. 20 
 21 
[C&D-N12]. Experimental design. There are several methods to estimate the limits from 22 
simple to complex approaches such as signal-to-noise ratio, standard deviation of blank 23 
samples, calibration curve (weighted or not) and pre-established area RSD values [65]. 24 
Presenting or discussing pros and cons of the different procedures developed for 25 
estimating LOD values are outside the aims of this manuscript. Anyway, in all methods 26 
some assumptions and simplifications are applied that are not always acceptable. This fact 27 
can significantly influence the estimated values. Additionally, it must be highlighted that the 28 
same LOD estimation approach is not automatically usable for all the analytical techniques 29 
due to differences in the way that analytical techniques provide instrument signals. 30 
Therefore, the LOD estimates obtained by different methodologies are not strictly 31 
comparable to each other and they can vary significantly even for the same analytical data 32 
[65]. This is the reason that MV guidelines often leave the analyst free to select the LOD 33 
acceptance criteria. Two recommendations relating to LOD are: i) The exact procedure for 34 
determination of LOD must be clearly stated in the document. If the method of estimation 35 
was not visibly indicated, usually results are not valid to be compared; ii) Estimated value 36 
for LOD, obtained by theoretical calculation, should be checked to get reliable values. 37 
Therefore, it is required the verification of estimate values by the analysis of independent 38 
samples around the LOD. 39 
 40 
3.2.8. Robustness/Ruggedness 41 
The consistency of an analytical method is addressed to the capacity of remain unaffected 42 
when different experimental conditions are deliberately applied so that the results obtained 43 
are completely reliable. Experimental conditions influencing the results of analyses are 44 
named critical and they should be evaluated and indicated in the validation report [66]. In 45 
order to decrease the quantity of tests required to evaluate this validation parameter a 46 
Plackett-Burman design with two levels per variable is suggested to be performed [67]. 47 
This approach is very efficient when only the main effect of the different factors is 48 
evaluated rather than to assess the value of each particular effect. 49 
 50 
 11 
[C&D-N13]. Terminology. Although robustness and ruggedness have been frequently 1 
used interchangeably, they refer to different characteristics and a distinction between them 2 
must be made [68]. Some controversy has been reported in the literature because the 3 
term robustness was first defined by Youden and Steiner for collaborative studies among 4 
different laboratories [69]. Therefore, ruggedness test can be considered as a precision 5 
study as a manner to check the transferability of the analytical method. Considering that 6 
reproducibility term has been agreed as alternative precision designation for validation 7 
purpose, thus it is recommended that ruggedness term should not be applied. On the 8 
contrary, robustness term was proposed more recently to measure the capacity of an 9 
analytical method to indicate its insensitivity against changes in the normal test conditions 10 
at single laboratory level [70]. Although there is a lack of uniformity and certainly a degree 11 
of confusion in the analytical literature, there are some factors useful to discriminate 12 
between them. Firstly, the test conditions varied (internal/external). Secondly, at which 13 
laboratory level (intralaboratory/interlaboratory). Thirdly, the stage when the study should 14 
be carried out. Ruggedness (reproducibility) test by interlaboratory studies must be 15 
performed at the late stage of MV. On the other hand, robustness test has been planned 16 
sometimes at the end of method development and therefore not considered strictly as a 17 
performance parameter. Alternatively, performing the test at the end of MV is senseless in 18 
avoiding waste of resources thinking in the option that a method is found not to be robust. 19 
Therefore, robustness study should be carried out at the start of MV once the method has 20 
been optimized, at least to some extent. 21 
 22 
4. Evaluation of controversies and discrepancies among MV guidelines 23 
4.1. Overall evaluation of performance parameters for MV 24 
The frequency of the validation parameters included in the MV guidelines were displayed 25 
in the Figure 1. These results revealed the high variability in the prevalence of each 26 
statistical validation parameter. The performance parameter most frequently included was 27 
precision (97%). Following, limit of detection (92%) and selectivity/specificity (89%). Later, 28 
calibration/linearity (84%).  Accuracy and trueness terms were both used, but the first one 29 
was mostly preferred (76% versus 43%). Robustness/ruggedness has a medium/low 30 
prevalence (65%).  Finally, for many analysts, the value of absolute recovery is not 31 
important because it was the performance parameter with lowest presence in the MV 32 
guidelines. However, the percentage increases intensely if both concepts (absolute and 33 
apparent) of recovery term are merged.  34 
  35 
4.2. Particular evaluation of performance parameters for MV 36 
Table 2 summarizes the discrepant information among MV guidelines. Following, the 37 
results of each performance parameter are individually evaluated considering, in each 38 
case, only the documents including the selected parameter. 39 
4.2.1. Selectivity/Specificity 40 
Different options were used to describe the ability of a method to determine an analyte 41 
without interferences from other components. Firstly, many MV guidelines included both 42 
terms but selectivity was designed as a preferred term (27%). Secondly, the use of each 43 
term alone was very similar for specificity (21%) and selectivity (18%). Another option 44 
reported was to use both terms together, as equivalent (21%) or as different (9%) terms. 45 
Following, one document included both terms but designating specificity as a preferred 46 
term (3%). Finally, it is important to highlight that in three MV documents the general term 47 










4.2.2. Calibration/Linearity/ Response Function 7 
The preferred terminology for this performance parameter was to use both terms 8 
(calibration and linearity) together (48%). Other options reported were to use the single 9 
term calibration (29%) or linearity (23%).   10 
In addition, MV guidelines include some general recommendations for preparing the 11 
calibration curve: 12 
 Using the same matrix in which the method will be applied later because there are 13 
often interactions with matrix components. 14 
 Applying the internal standard, mainly for chromatographic methods, as a way to 15 
improve the results obtained.  16 
 A minimum of five-six calibration levels, sometimes suggesting a blank sample 17 
(matrix without analyte and internal standard), and a zero sample (matrix without 18 
analyte but with internal standard). 19 
 Some discussions still remain concerning the selection of these levels as well as 20 
their equidistant or non-equidistant separation.  21 
 Similarly, the number of replicate measurement is widely variable among MV 22 
guidelines.  23 
 Unfortunately, only a few documents suggest to study the calibration curve in 24 
different series or days (at least three) as a way to evaluate the stability or 25 
variability of the instrument response.  26 
 27 
MV guidelines were evaluated according to the relationship between concentration and 28 
instrument signal. Around 73% of documents included the possibility that the relationship 29 
cannot be linear, mainly quadratic. Therefore, about 27% of documents limited the 30 
goodness-of- fit to simplest linear model. Relating to the selection of calibration model, that 31 
means OLS versus WLS, this decision is critical to avoid biasing the regression line in 32 
favour of the calibration standards at high concentration. However, only about 45% of MV 33 
guidelines, mainly for biological samples determinations, suggested the use of WLS model 34 
and weighting factor (usually 1/x or 1/x2). That means WLS model was not included in the 35 
majority of documents. In addition, MV guidelines included different procedures to evaluate 36 
the goodness-of-fit of the selected calibration model, although the values of r and/or R2 37 
were selected in 61% of documents. Anyway, around half of these MV guidelines criticize 38 
the use of r and/or R2 as a good indicator to evaluate the goodness-of-fit. On the other 39 
hand, %RE was suggested in only 9 out of 33 documents (27%) where acceptance criteria 40 
were included, being recommended in 4 out of 8 (50%) analytical MV guidelines for 41 
biological matrices. 42 
 43 
4.2.3. Accuracy  44 
The evaluation of selected MV guidelines clearly showed that there is no consensus at all 45 
on the definition of accuracy. On the one hand, 57% of documents that used this term refer 46 
to a single performance parameter. On the other hand, in 43% of documents accuracy was 47 
considered as a dual parameter concept serving to define the total analytical error.  48 
Analogous results of lack of agreement were obtained in the evaluation of accuracy (or 49 
trueness) and precision by using combined or separate experiments. Exactly, 57% versus 50 
 13 
43% of MV guidelines suggested to evaluate them by using single or combined 1 
experiments, respectively.  2 




4.2.4. Precision 7 
Though official guidelines suggested the precision levels were widely variable. In the 8 
majority of documents, the three typical levels (repeatability, intermediate precision and 9 
reproducibility) were reported (44%). Later, only repeatability and intermediate precision 10 
were suggested in many MV guidelines (36%). Other minor options reported were to 11 
evaluate only repeatability and reproducibility (8%) or repeatability alone (6%). 12 
Unfortunately, there are only two documents (6%) that include the four types of precision, 13 
which means adding the instrument precision to the three typical levels of method 14 
precision. Other subject of interest is the terminology used to define the variability of 15 
results when the experimental conditions are varied at single laboratory. The term 16 
intermediate precision was used in 42% of documents. Different alternative terms were 17 
selected such as within-lab reproducibility, intralaboratory reproducibility, within-run 18 
precision, internal precision, run to run precision. Exceptionally, two documents used the 19 
term ruggedness for this kind of intermediate precision.    20 
 21 
4.2.5. Trueness 22 
It is important to note that this performance parameter is particularly controversial and a 23 
typical case of mistaken terminology used in several MV guidelines. Firstly, the terms 24 
accuracy and trueness are used as synonymous. Secondly, the trueness (or accuracy) of 25 
an analytical method was quantitatively expressed using different terms such as bias, 26 
relative bias or recovery. The evaluation of selected MV guidelines showed that the terms 27 
used were recovery (41%), bias and recovery (34%) and bias (25%). Surprisingly, five 28 
documents had no information at all about systematic error nomenclature.  29 
On the other hand, it was previously commented the significance that the term apparent 30 
recovery should be used unequivocally instead of recovery to express the ratio of the 31 
concentration found versus the reference value. Probably due to nomenclature 32 
simplification but, considering that many documents (75%) include recovery term in the 33 
text of MV guidelines, it is difficult to understand that only two documents such as 34 
Eurachem [19] and NMKL [29] included apparent recovery as the correct terminology. 35 
Additionally, IUPAC guideline [25] for single laboratories used the alternative terms of 36 
surrogate or marginal recovery. 37 
 38 
4.2.6. Recovery 39 
Significant confusion of the recovery parameter has been observed in the documents. 40 
Different validation guidelines (19%) from the total selected, mainly for BMV, refer to 41 
recovery from the sample preparation point of view and the term is mostly used as a 42 
parameter concerning extraction efficiency. In fact, some guidelines such as ISO 12787 43 
[24] and USFDA-CDER-BMV [39] specified that recovery is related to extraction efficiency. 44 
However, there are some exceptions and recovery term was not mentioned in EMA 45 
guideline [17]. The organisation argues that recovery is an issue to be investigated during 46 
the analytical method development and as such is not considered to be included in the MV 47 
guideline. On the other hand, although recovery is described in some documents as a 48 
particular performance parameter, really it was previously explained that recovery term is 49 
used wrongly as a measure of accuracy/trueness. In any case, interpretation of recovery 50 
 14 
from extraction or spiking point of view can be considered as a significant subject from MV 1 





4.2.7. Limit of detection 7 
This is a performance parameter with serious differences in terminology, the experimental 8 
procedure and the method of calculation. Firstly, LOD term was used in the majority of MV 9 
guidelines (50%). Alternative terms were detection limit (24%), method detection limit 10 
(9%), low limit of quantitation (9%) and CCβ (6%). Secondly, relating to the methodology 11 
for calculation, there are many MV guidelines where this information is missing (41%). 12 
Alternatively, more than one method of calculation was reported in 32% of documents 13 
while the use of blank samples was suggested in 21% of documents. Lastly, the method of 14 
calibration curve and the signal to noise ratio was used exceptionally one time each (3%). 15 
On the other hand, it was previously explained that the only way to get reliable LOD values 16 
is by verification of the theoretical values obtained. Unfortunately, the recommendation for 17 
checking the theoretic results was only incorporated in 5 out of 34 documents (15%) where 18 
this parameter was assessed. 19 
 20 
4.2.8. Robustness/Ruggedness 21 
Both terms are used to express the consistency of an analytical method when different 22 
experimental conditions are intentionally applied. Ruggedness is the term preferred in the 23 
majority of MV guidelines (42%). It is important to highlight that this is a very controversial 24 
subject because ruggedness was a term selected to check the variability of results among 25 
different laboratories and the majority of documents evaluated are relating to single 26 
laboratory validation. Alternatively, robustness/ruggedness together have been used in 27 
33% of documents. However, the utilization of robustness, which can be considered as the 28 
correct term, was suggested only in 25% of documents.  29 
 30 
5. Suggestions by the authors 31 
From this review manuscript, the terms that should be used for analytical MV are:  32 
 Selectivity, as a measure of interference in the process. 33 
 Response function and goodness-of-fit, when choosing the calibration model. 34 
 Accuracy, as a two component parameter formed by precision and trueness. 35 
 Repeatability, intermediate precision and reproducibility, as the terms to define the 36 
precision or the method random error. 37 
 Trueness, as the general characteristic to measure the systematic error. In addition, 38 
bias or apparent recovery should be used unambiguously when referring to the 39 
measurement of systematic error. 40 
 Recovery, should be limited when a study is focused in the concentration or 41 
extraction stage. 42 
 Limit of detection, or detection limit, as a form to define statistically the confidence 43 
of measurement at low concentrations. 44 
 Robustness, as the consistency of an analytical method at single laboratory level.   45 
 46 
Some suggestions for other controversial subjects corresponding to experimental 47 
procedure and acceptance criteria of analytical MV are: 48 
 Instrument precision should be complementary firstly evaluated to the three typical 49 
method precision levels. 50 
 15 
 Calibration curve should be selected including the options of a non-linear and WLS 1 
models. 2 
 Goodness-of-fit for calibration model should be never based on r and or R2 values. 3 
The parameter to take into account for evaluation should be % RE of back 4 
calculated concentrations. 5 
 Accuracy study should be carried out by combined experiments of precision and 6 
trueness using different samples from calibration process. 7 
 Methodology used to evaluate theoretical LOD values should always be reported. 8 
Additionally, these values should be verified experimentally at laboratory level. 9 
 10 
6. Conclusions 11 
When selecting an analytical method to be used at the laboratory, its validity depends on 12 
the particular MV guideline selected because there are many options which can differ in 13 
terminology, experimental procedure and acceptance criteria. The main problem among 14 
MV guidelines is relating to the terminology used in the different analytical fields. 15 
Unfortunately, the diverse performance parameters are not always clearly defined in order 16 
to avoid suspicious MV procedures. Therefore, a consensus on a common terminology for 17 
validation is required. Similarly, agreement in the experimental procedure and acceptance 18 
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Table 1. Summary of the analytical method validation guidelines evaluated. 
GUIDE ACRONYM ORGANIZATION NAME 
NATIONAL or 
INTERNATIONAL 
MATRICES AREA or DISCIPLINE YEAR REFERENCE 
1 AAFS-ASB 
American Academy Forensic Sciences 
Academic Standard Board 
National Biological forensic 2019 [7] 
2 ANVISA Brazilian Sanitary Surveillance Agency National Analytical pharmaceutical 2003 [8] 
3 ANVISA Brazilian Sanitary Surveillance Agency National Biological drugs 2003 [8] 
4 AOAC Association of Analytical Communities International Analytical foods 2002 [9] 
5 APVMA 
Australian Pesticides & Veterinary 
Medicines Authority 
National Analytical 
active constituents, agricultural 




American Society for Testing and 
Materials 
International Analytical metals, ores materials 2011 [11] 
7 CD 96/23/EC Commission Decision of European Union International Analytical 




The European Committee for 
Standardization 
International Analytical environmental samples 2008 [13] 
9 CIPAC 
Collaborative International Pesticides 
Analytical Council 




Community and National Reference 
Laboratories Food Contact Materials 
International Analytical food contact materials 2009 [15] 
11 EDES 
Europe and Africa, Caribbean and Pacific 
countries 
International Analytical food and feedstuffs 2013 [16] 
12 EMA The European Medicines Agency International Biological drugs 2011 [17] 
13 ENFSI 
The European Network of Forensic 
Science Institutes 
International Biological forensic 2014 [18] 
14 EURACHEM Eurachem International Analytical not specified 2014 [19] 
15 FAO-IAEA 
Food & Agriculture Organization 
International Atomic Energy Agency 
International Analytical food 1998 [20] 
16 GTFCh The Society of Toxicological & Forensic International Biological forensic 2009 [21] 
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GUIDE ACRONYM ORGANIZATION NAME 
NATIONAL or 
INTERNATIONAL 
MATRICES AREA or DISCIPLINE YEAR REFERENCE 
Chemistry 
17 ICH 
The International Council for 
Harmonization of Technical 
Requirements for Pharmaceuticals 
International Analytical pharmaceutical 2005 [22] 
18 INAB The Irish National Accreditation Board National Analytical chemical analysis 2019 [23] 
19 ISO 12787 
The International Organization for 
Standardization 
International Analytical cosmetics 2011 [24] 
20 IUPAC 
The International Union of Pure & 
Applied Chemistry 
International Analytical not specified 2002 [25] 
21 MHLW 
The Ministry of Health, Labour and 
Welfare-Japan 
National Biological drugs 2013 [26] 
22 NATA 
The National Association of Testing 
Authorities - Australia 
National Analytical not specified 2018 [27] 
23 NELAC-TNI 
The National Environmental Laboratory 
Accreditation Institute 
National Analytical environmental samples 2016 [28] 
24 NMKL The Nordic Committee on Food Analysis International Analytical 
food, drinking water or animal 
feed 
2009 [29] 
25 NORD-VAL The Nordic Validation International International Analytical chemical methods (test kits) 2010 [30] 
26 OECD 
The Organization of Economic 
Co-Operation & Development 
International Analytical biocides 2014 [31] 
27 OIV 
The International Organization of Vine & 
Wine 
International Analytical wine 2005 [32] 
28 SANTE 
The Directorate-General for Health and 
Food safety 
International Analytical 
pesticide residues and analysis 
in food and feed 
2017 [33] 
29 SFSTP 
The French Society of Pharmaceutical 
Sciences & Techniques 
National Analytical pharmaceutical 2007 [34] 
30 SWGTOX 
The Scientific Working Group for 
Forensic Toxicology 
International Biological forensic 2013 [35] 
31 USEPA 
The United States Environmental 
Protection Agency 
National Analytical environmental samples 1992 [36] 
32 USEPA-FEM  National Analytical chemical methods 2016 [37] 
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GUIDE ACRONYM ORGANIZATION NAME 
NATIONAL or 
INTERNATIONAL 
MATRICES AREA or DISCIPLINE YEAR REFERENCE 
USEPA-Forum on Environmental 
Measurements 
33 USFDA-CDER Centre for Drug Evaluation & Research National 
Analytical and 
biological 





Centre for Veterinary Medicine 
National Biological drugs 2018 [39] 
35 USFDA-FVM 
 
Foods & Veterinary Medicine Program 
National Analytical 
food, feed, cosmetics, and 
veterinary products 
2019 [40] 
36 USP The United States Pharmacopeia National Analytical pharmaceutical 2016 [41] 

































1 INTERF. CAL 2/WLS YES
1
 X COMB 1/2 NO/run NO/bias X YES VAR
5
 X [7] 
2 SEL/SPE LIN 1/OLS YES 1 X 1/2/3 IP/run NO/recov NO YES Cal ROBU [8] 
3 SPE CAL/LIN 2/OLS YES
3
 1 X 1/2 NO/run NO/recov YES NO/DL None X [8] 
4 SEL (SPE) CAL 2/WLS YES
1
 1 X 1/2/3 IP/labor NO/recov NO NO/determ Blanks RUGG [9] 
5 SEL (SPE) LIN 2/OLS YES 1 X 1/2/3 IP NO/recov NO YES SDlowconc X [10] 
6 SEL CAL NO/NO NO
3
 2 X 1/2/3 IP/labor NO/bias X YES None RUGG [11] 
7 SPE X X X 2 X 1/2/3 NO/wlrepr YES/recov YES (error) NO/CCβ Cal/Blanks RUGG [12] 
8 X X X X X X 1/3 X X X X X ROBU [13] 
9 SPE LIN 2/NO YES 1 X 1 X NO/recov NO X X X [14] 
10 SEL/SPE CAL/LIN 2/WLS YES
2/3
 2 X 1/2/3 IP/wlrepr YES/bias-rec NO YES/MDL VAR ROBU/RUGG [15] 
11 SEL/SPE CAL/LIN NO/WLS NO 2 X 1/2/3 NO/wlrepr YES/bias YES YES Blanks ROBU/RUGG [16] 
12 SEL&SPE CAL NO/NO NO
3
 1 COMB 1/2 NO/run X X NO/LLOQ None X [17] 
13 SEL (SPE) LIN NO/NO NO X X 1/2 NO/wlrepr YES/bias X YES None ROBU/RUGG [18] 
14 SEL CAL/LIN NO/NO NO 2 X 1/2/3 IP YES/bias-rec
4
 NO YES Blanks ROBU/RUGG [19] 
15 SPE X X X 1 X 1/2/3 NO/wlrepr NO/recov NO YES None X [20] 
16 SEL (SPE) CAL/LIN 2/WLS NO 2 COMB 1/2/3 IP YES/bias YES YES SNR/Cal ROBU/RUGG [21] 
17 SPE LIN NO/OLS YES 1 X 1/2/3 IP NO/recov NO YES VAR
5
 ROBU [22] 
18 SEL (SPE) CAL/LIN 2/WLS YES
1
 2 X 1/2 NO/intlabrepr YES/bias-rec YES (error) NO/DL Blanks ROBU/RUGG [23] 
19 SEL&SPE CAL/LIN 2/WLS YES 1 X 1/2/3 IP NO/recov YES YES SNR/Cal X [24] 
20 SEL CAL/LIN 2/WLS YES
1
 X X 1/2 NO/run YES/bias-rec YES (error) YES/DL Blanks RUGG [25] 
21 SEL (SPE) CAL 2/WLS NO
3
 1 COMB 1/2 NO/run X YES NO/LLOQ None X [26] 
22 SEL (SPE) CAL/LIN 2/WLS YES
1
 2 X 0/1/2/3 IP/wl-intr repr YES/bias-rec NO YES VAR RUGG [27] 
23 SEL CAL 2/OLS YES
3
 X COMB X NO NO/bias-rec NO NO/MDL None
5
 X [28] 
24 SPE ST.CURV. 2/NO YES
1
 X X 1/2/3 NO/inter repr YES/recov
4
 NO YES Blanks/Cal RUGG [29] 
25 SPE X X X X X 1/2 NO/inter repr YES/bias-rec YES (error) NO/CCβ Blanks RUGG [30] 
26 SEL/SPE CAL/LIN 2/NO YES 1 X 1 NO NO/recov NO YES None X [31] 
27 SEL CAL/LIN 2/WLS YES
1






























28 SEL (SPE) CAL/LIN 2/WLS NO
3
 2 COMB 1/2 NO/wlrepr YES/bias-rec NO X X ROBU [33] 
29 SEL/SPE CAL/LIN/R.F. 2/WLS YES
1/3
 2 COMB 1/2 IP YES/bias-rec NO YES None X [34] 
30 INTERF. CAL 2/WLS YES
1
 X COMB 1/2 NO/run NO/bias X YES VAR X [35] 
31 INTERF. X 2/NO NO 1 X 1/3 NO/longtermpr NO/bias-rec NO NO/MDL None RUGG [36] 
32 SEL CAL 2/NO NO 2 COMB 1/3 NO YES/bias X NO/DL None
5
 RUGG [37] 
33 SEL/SPE LIN 2/NO YES 1 COMB 0/1/2/3 IP/ruggedness NO/recov YES (error) NO/DL SNR ROBU [38] 
34 SEL&SPE CAL 2/NO NO
3
 1 COMB 1/2 NO/run X YES NO/LLOQ None X [39] 
35 SEL (SPE) CAL/LIN NO/NO NO 2 X 1/2/3 IP YES/bias YES YES None ROBU/RUGG [40] 
36 SPE (SEL) LIN 2/WLS YES 1 COMB 1/2/3 IP/ruggedness NO/recov NO NO/DL VAR
5
 ROBU [41] 
37 SEL/SPE CAL/LIN NO/NO NO 1 X 1/2/3 IP X YES (error) NO/DL VAR ROBU/RUGG [42] 
Explanation about controversies and discrepancies (C&D) nomenclature of Table 2. 
N1 (SEL): used terminology related to “selectivity” 
SEL: only the term “selectivity” is considered 
SPE: only the term “specificity” is considered 
SEL(SPE) or SPE(SEL): the terms “selectivity” and 
“specificity” are distinguished and the execution only of 
what is outside the parentheses is considered 
SEL/SPE: the terms “selectivity” and “specificity” are used 
as synonyms 
SEL&SPE: the terms “selectivity” and “specificity” are 
distinguished and the execution of both are considered 
INTERF.: the term “interference” is used. 
N8 (PREC-2): used terminology related to “precision” – the guideline considers “intermediate 
precision"/other related terms 
NO or IP: does not consider “intermediate precision” OR considers it 
Other related terms: run, labor, wlrepr (within-laboratory reproducibility), intlabrepr (inter-laboratory 
reproducibility), wl-intrrepr (within-laboratory reproducibility and intra-laboratory reproducibility), inter 
repr (internal reproducibility), runtorun, longtermpr (long-term precision), ruggedness 
N2 (LIN-1): used terminology related to “linearity” 
LIN: only the term “linearity” is considered 
CAL: only the term “calibration” is considered 
CAL/LIN: both terms, “calibration” and “linearity”, are 
considered 
CAL/LIN/R.F.: three terms are considered - calibration, 
linearity and response function 
ST.CURV.: the term “standard curve” is considered. 
N9 (TRUE): used terminology related to “trueness” 
YES: the term “trueness” is used 
NO: the term “trueness” is not used 
Bias: “trueness” is expressed using the term “bias” 
Recov: “trueness” is expressed using the term “recovery” 
Bias-rec: “trueness” is expressed using the terms “bias and recovery” 
Superscript 4: the guide mentions the term “apparent recovery" 
N3 (LIN-2): selection of the calibration model 
1: linear equation 
N10 (RECO): used terminology related to “recovery” 
YES: “recovery” is considered a specific parameter 
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2: nonlinear equation 
OLS: ordinary model 
WLS: weighted model 
NO: does not specify about the equation's linearity or about 
the considered model. 
NO: “recovery” is not considered a specific parameter 
YES (error): really is “apparent recovery”. 
N4 (LIN-3): acceptance criteria 
YES: use r and/or R
2
 as criterion for goodness-of-fit 
NO: does not use r and/or R
2
 as criterion for goodness-of-fit 
Superscript 1: critique using r and/or R
2
 
Superscript 2: wrong definition of r and/or R
2
 
Superscript 3: use percentage of relative error as criterion for 
goodness-of-fit. 
N11 (LOD-1): used terminology related to “limit of detection” 
YES: the term “limit of detection” is used 
NO: the term “limit of detection” is not used 
Alternative designations: DL (detection limit); determ (limit of determination); CCβ (detection capability); 
MDL (method detection limit); LLOQ (lower limit of quantification). 
N5 (ACC-1): used terminology related to “accuracy” 
1: accuracy as an individual parameter as a measure of the 
systematic error 
2: accuracy as a set of parameters (precision and trueness). 
N12 (LOD-2): suggested method for estimating the “limit of detection” 
VAR (various); None; Blanks; Cal (calculated); SDlowconc (standard deviation - lowest calibration 
standard); SNR (signal-to-noise ratio) 
Superscript 5: it is suggested to check LOD experimentally. 
N6 (ACC-2): single versus combined experiments 
COMB.: accuracy evaluation is carried out in combination 
with precision experiments 
N13 (ROBU): used terminology related to “robustness”. ROBU: only the term “robustness” is 
considered 
RUGG: only the term “ruggedness” is considered 
ROBU/RUGG: both terms “robustness and ruggedness” are considered. 
N7 (PREC-1): precision levels 
0: precision is associated with “instrument precision” 
1: precision is associated with “repeatability” 
2: precision is associated with “intermediate precision” 
3: precision is associated with “reproducibility”. 
X: Information about the parameter is not included in the guideline. 
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Figura 1 
 
 
 
 
